{"id":"W3107922790","doi":"10.1016/j.pan.2020.10.008","title":"Organoid Personalized Therapeutics and the Pancreatic Adenocarcinoma Signature Stratification for treatment (PASS) – 01 trial","year":2020,"lang":"en","type":"article","venue":"Pancreatology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; FOLFIRINOX; Oncology; Pancreatic cancer; Internal medicine; Gemcitabine; Chemotherapy; Biomarker; Progression-free survival; Transcriptome; Erlotinib; Cancer; Irinotecan; Colorectal cancer; Gene; Gene expression","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001395877,0.0005129784,0.0009800008,0.0001423412,0.0001949914,0.001201287,0.0003308172,0.0006074315,0.004855805],"category_scores_gemma":[0.001706722,0.0001475731,0.001508184,0.0002451978,0.0004763694,0.0008981999,0.0006040902,0.002127733,0.0007196001],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005901781,"about_ca_system_score_gemma":0.0008902382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000361193,"about_ca_topic_score_gemma":0.001103633,"domain_scores_codex":[0.9995746,0.0002360994,0.00001624277,0.00007505482,0.00003561578,0.00006241816],"domain_scores_gemma":[0.9992681,0.000200979,0.0001723343,0.000116951,0.0000405447,0.0002010876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6803245,0.002925436,0.03458904,0.001333761,0.007328727,0.0002975843,0.0002269163,0.007255773,0.01078964,0.004050441,0.02512475,0.2257534],"study_design_scores_gemma":[0.3803143,0.2496127,0.2070784,0.0009330718,0.02085469,0.001614499,0.0006755364,0.01552519,0.01343202,0.02511808,0.0845755,0.0002659409],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980642,0.00346276,0.000968247,0.002679748,0.0003125018,0.000284021,0.002757343,0.0001397748,0.008753654],"genre_scores_gemma":[0.9823695,0.001532165,0.00192393,0.002108566,0.0003166165,0.0003471027,0.006203397,0.00004429503,0.005154225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004855805,"threshold_uncertainty_score":0.01624429,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07600460637495861,"score_gpt":0.3475347002636003,"score_spread":0.2715300938886417,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}